title: Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
abstract: BACKGROUND
  Paraoxonase is a serum enzyme, which prevents oxidation of low-density lipoprotein (LDL) by hydrolyzing lipid peroxides. Two polymorphisms in PON1 gene have been associated with cardiovascular and microvascular diseases in both diabetic and non-diabetic patients.
  
  
  OBJECTIVE
  The current project was designed to investigate the association between the polymorphisms of two PON genes and diabetes microvascular diseases (retinopathy and microalbuminuria) and any potential linkage between Met54Leu of PON1 and Cys311Ser of PON2 gene.
  
  
  METHODS
  Diabetic retinopathy and albumin excretion rate were assessed in 372 adolescents with Type 1 diabetes who were genotyped for the two polymorphisms.
  
  
  RESULTS
  We confirmed the increased susceptibility for diabetic retinopathy for the Leu/Leu genotype (odds ratio (OR) 3.34 (confidence interval (CI) 1.95, 5.75), P < 0.0001). The Ser/Ser genotype was significantly more common in those patients with microalbuminuria (albumin excretion rate > or = 20 microg/min) compared with those with albumin excretion rate < 20 microg/min (OR 4.72 (CI 2.65, 8.41), P < 0.0001). The Ser311 of PON2 was in strong linkage disequilibrium with Leu54 of PON1 gene (Delta = 23 x 10(4), P < 0.001). The delta value was higher for those without complications (28 x 104, P < 0.001) compared with those with complications (15.5 x 10(4), P < 0.001).
  
  
  CONCLUSIONS
  This study supports the hypothesis that diabetic microangiopathy is genetically heterogeneous. PON1 Leu/Leu increases the risk for retinopathy and PON2 Ser/Ser increases the risk for microalbuminuria.
authors.affiliation: Ray Williams Institute of Paediatric Endocrinology, Diabetes and Metabolism, The Children's Hospital at Westmead, Westmead, Australia.
authors.forename: Y
authors.initials: Y
authors.lastname: Kao
authors.forename: K C
authors.initials: KC
authors.lastname: Donaghue
authors.forename: A
authors.initials: A
authors.lastname: Chan
authors.forename: B H
authors.initials: BH
authors.lastname: Bennetts
authors.forename: J
authors.initials: J
authors.lastname: Knight
authors.forename: M
authors.initials: M
authors.lastname: Silink
mesh_terms: D000293:Adolescent; D019943:Amino Acid Substitution; D043303:Aryldialkylphosphatase; D002648:Child; D002784:Cholesterol / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000235:genetics*; D003928:Diabetic Nephropathies / Q000235:genetics; D003930:Diabetic Retinopathy / Q000235:genetics; D004950:Esterases / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D005810:Multigene Family; D012307:Risk Factors
chemical_list: D005819:Genetic Markers; D002784:Cholesterol; D004950:Esterases; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human